September 23, 2019 by Johnson Paul
According to the latest report published by Credence Research, Inc. “Oral Thin Film Drugs Market (Product Type – Oral Thin Film: Sublingual Film, Fully Dissolving Buccal Film); (Type of Indication – Migraine, Schizophrenia, Alzheimer’s Disease, Nausea & Vomiting, Opioid Dependence and Others) - Growth, Future Prospects and Competitive Analysis, 2017-2025,” The market for Oral thin film drugs is expected to expand to CAGR by 8.9 percent from 2017 to 2025.
Oral thin films are thin, flexible drug delivery movies that dissolve in oral mucosa leading in fast onset of action and enhanced bioavailability of drugs. Oral thin film is mostly used for geriatric, pediatric and bedridden patients who are unable to take a strong form of the drug. Pharmaceutical companies are carrying out tremendous R&D to change their current medicines to fast-dissolving oral thin film medicines.
Browse the full report at https://www.credenceresearch.com/report/oral-thin-film-drugs-market
According to statistics, 4 out of 5 patients prefer disintegrating oral dosage forms over standard strong oral dosage forms. Furthermore, the implementation of oral thin films is not restricted to oral devices, but is also extended to gastro-retentive and sublingual distribution systems. In terms of indication, the market for oral thin film medicines is segmented as migraine, schizophrenia, Alzheimer's disease, nausea & vomiting, opioid reliance and others. The pharmaceutical industry focuses its focus on shortening the timelines for drug development and effective drug delivery platforms. In addition, there is an growing demand for effective drug delivery techniques as well as comfort in the transport of drugs that have fueled the market for oral thin film medicines in the latest past. Based on the type of products, the market for oral thin film medicines is segmented into a sublingual film and a fully dissolving oral film. The sublingual film retained the biggest share in the market for oral thin film medicines owing to its ease of use and efficiency as it ensures fast dissolution of the drug without water intake and fast onset of action when supplied orally.
Geographically, North America was observed as the largest regional segment in the oral thin film drugs market. U.S. led the North America oral thin film drugs market, accounting for more than 80% of the market share due to advanced technologies used in the pharmaceutical research and development for the discovery of novel drug delivery technique. Moreover, rising demand for efficient drug delivery route and its acceptability in the region would further drive the oral thin film drug market in the future. Asia Pacific is anticipated to exhibit highest growth rate during the forecast period due to favorable regulation, growing awareness among the masses and introduction of novel products leading to the growth of healthcare infrastructure which would boost the demand for oral thin film drugs in the region.
Market Competition Assessment:
The oral thin film drugs market currently have comprises number of players operating in the market such as Monosol Rx, Tesa Labtec GmbH, Pfizer, Inc., Novartis AG, Solvay, Allergan plc, IntelGenx and others currently operating in the market.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58781
Key Market Movements:
By Product Type
Oral Thin Film
By Indication Type
By Geography Segment